Search Thermo Fisher Scientific
- Order Status
- Quick Order
-
Don't have an account ? Create Account
Search Thermo Fisher Scientific
One Lambda Devyser™ Accept™ cfDNA assay is an NGS assay designed to detect and analyze circulating dd-cfDNA in post-transplant human plasma samples. Its unique indel design allows for accurate results, reduces amplification and sequencing errors. Combined with an efficient workflow, Accept cfDNA can be ideal tool for post-transplant testing and may provide early time to result when run in your own in house HLA lab.
Designed to provide accurate and sensitive detection of microchimerism levels in stem cell transplant samples, the One Lambda Devyser Chimerism NGS assay is perfect for HLA and molecular core labs associated with HSCT Programs.
MMDx Heart and MMDx Kidney complement conventional biopsy processing to improve the assessment of rejection and injury in transplanted organs. These Laboratory Developed Tests use a GeneChip™ Custom Microarray to measure mRNA transcript levels in biopsies along with extensive big data derived from individuals and populations.
Not all products are CE marked or have 510(k) clearance for sale in the U.S. Availability of products in each country depends on local regulatory marketing authorization status.
MMDx-Heart and MMDx-Kidney are tests that were developed and validated by Kashi Clinical Laboratories, Inc. The laboratory developed tests are used for clinical purposes by the CLIA-certified laboratory performing the test. These tests have not been cleared or approved by the US FDA or CE marked in the EU as an in vitro diagnostic test.
MMDx and Molecular Microscope are trademarks of Transcriptome Sciences Inc.